Adverum Biotechnologies
Yahoo Finance • 2 days ago
Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream
MIAMI, Sept. 24, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. The Emerging Growth Conference identifie... Full story
Yahoo Finance • 3 days ago
Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream
MIAMI, Sept. 23, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. The Emerging Growth Conference identifie... Full story
Yahoo Finance • 20 days ago
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified s... Full story
Yahoo Finance • last month
Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream
MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025. The Emerging Growth Conference identifies co... Full story
Yahoo Finance • last month
Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream
MIAMI, Aug. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025. The Emerging Growth Conference identifies co... Full story
Yahoo Finance • last month
Hospital Information Systems Company Evaluation Report 2025 | Epic Systems, AdvancedMD, and Dedalus Lead with Integrated EHR, Practice Management, and Digital Transformation Solutions
Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Hospital Information Systems Company Evaluation" report has been added to ResearchAndMarkets.com's offering. The Hospital Information System Companies Quadrant is a comprehensive industr... Full story
Yahoo Finance • 2 months ago
Adverum Biotechnologies to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
REDWOOD CITY, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that Laurent Fischer, MD, President and Chief Executive Officer, and Szilárd Kiss, MD, Distinguished Professor of Ophtha... Full story
Yahoo Finance • 2 months ago
Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream
MIAMI, July 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025. The Emerging Growth Conference identifies comp... Full story
Yahoo Finance • 2 months ago
Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream
MIAMI, July 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025. The Emerging Growth Conference identifies comp... Full story
Yahoo Finance • 3 months ago
Adverum Biotechnologies price target lowered to $12 at Mizuho
Investing.com - Mizuho lowered its price target on Adverum Biotechnologies (NASDAQ:ADVM) stock to $12.00 from $16.00 on Wednesday, while maintaining an Outperform rating on the shares. The stock, currently trading at $2.58, sits well below... Full story
Yahoo Finance • 3 months ago
Adverum Biotechnologies' SWOT analysis: gene therapy stock faces pivotal year
Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a biotechnology company focused on developing gene therapies for ocular and rare diseases, stands at a critical juncture in its journey to bring innovative treatments to market. With a market ca... Full story
Yahoo Finance • 5 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adverum Biotechnologies, Inc. (“Adverum” or the “Company”) (NASDAQ: ADVM). Such investors are advised to contact Danielle Peyton... Full story
Yahoo Finance • 5 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adverum Biotechnologies, Inc. (“Adverum” or the “Company”) (NASDAQ: ADVM). Such investors are advised to contact Danielle Peyt... Full story
Yahoo Finance • 5 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adverum Biotechnologies, Inc. (“Adverum” or the “Company”) (NASDAQ: ADVM). Such investors are advised to contact Danielle Peyton... Full story
Yahoo Finance • 5 months ago
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones
REDWOOD CITY, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy to preserve sight for life in highly prevalent ocular diseases, today repo... Full story
Yahoo Finance • 6 months ago
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted an inducement award consisting of non-qualified... Full story
Yahoo Finance • 6 months ago
Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference
REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, today anno... Full story
Yahoo Finance • 7 months ago
Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD
Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMDARTEMIS is the first-ever initiation of a regis... Full story
Yahoo Finance • 7 months ago
Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference
REDWOOD CITY, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, today annou... Full story
Yahoo Finance • 2 years ago
Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference
REDWOOD CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today anno... Full story
